Cabaletta Bio CABA
NASDAQ CABA
$3.46 -0.02 (-0.57%)
As of: Sep 4, 2026 · 3:59 PM EDT

Cabaletta Bio (CABA) Change in Account Payables (2018 - 2025)

Cabaletta Bio (CABA) posted quarterly Change in Account Payables of -$1.7 million for Q4 2025, down 163.12% year-over-year from $2.7 million in Q4 2024, and down 259.44% quarter-over-quarter from $1.1 million in Q3 2025.

Analysis

Cabaletta Bio (CABA) Change in Account Payables (2018 - 2025) Analysis & Trends

Cabaletta Bio's Change in Account Payables history runs 8 years deep, the most recent figure standing at -$1.7 million for Q4 2025.

  • In Q4 2025, Change in Account Payables fell 163.12% year-over-year to -$1.7 million; the TTM figure through Dec 2025 stood at $1.5 million (up 53.31% YoY), while the FY2025 annual figure was $1.5 million, up 53.31% from the prior year.
  • Change in Account Payables for Q4 2025 stood at -$1.7 million, down from $1.1 million in the prior quarter.
  • The five-year high for Change in Account Payables was $2.7 million in Q4 2024, with the low at -$2.0 million in Q3 2024.
  • The 5-year median for Change in Account Payables is $580500.0 (2021), against an average of $259150.0.
  • Peak annual rise in Change in Account Payables reached 620.36% in 2022, while the deepest fall reached 304.07% in 2022.
  • Cabaletta Bio's Change in Account Payables stood at $566000.0 in 2021, then surged by 81.45% to $1.0 million in 2022, then tumbled by 49.56% to $518000.0 in 2023, then soared by 421.81% to $2.7 million in 2024, then slumped by 163.12% to -$1.7 million in 2025.
  • Business Quant data shows CABA's Change in Account Payables at -$1.7 million in Q4 2025, $1.1 million in Q3 2025, and $595000.0 in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -66.70 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -8.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 5.03 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 37.53 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Cabaletta Bio 522.26 Mn 522.26 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -1.71 Mn
Sep 30, 2025 1.07 Mn
Jun 30, 2025 595,000.00
Mar 31, 2025 1.59 Mn
Dec 31, 2024 2.70 Mn
Sep 30, 2024 -2.01 Mn
Jun 30, 2024 -1.34 Mn
Mar 31, 2024 1.66 Mn
Dec 31, 2023 518,000.00
Sep 30, 2023 1.30 Mn
Jun 30, 2023 -1.87 Mn
Mar 31, 2023 1.72 Mn
Dec 31, 2022 1.03 Mn
Sep 30, 2022 -893,000.00
Jun 30, 2022 -1.87 Mn
Mar 31, 2022 1.71 Mn
Dec 31, 2021 566,000.00
Sep 30, 2021 -221,000.00
Jun 30, 2021 959,000.00
Mar 31, 2021 -329,000.00